CTRI/2025/10/096283尚未招募Unknown
A Clinical study to evaluate the Sun protection factor of Honasa Beetroot Sunscreen (AP5H086)
Honasa Consumer Pvt. Ltd1 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2025年11月6日
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
- 入组人数
- 10
- 试验地点
- 1
- 主要终点
- Change in Individual MED (iMED) score
研究概览
简要总结
This is the Invivo SPF test done as per UV-B protection ISO 24444 to determine the Sun Protection Factor
Test Product:
1. Beetroot Sunscreen (AP5H086)
Done on 10 human volunteers. Duration: 3 Days
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18.00 Year(s) 至 65.00 Year(s)（—）
- 性别
- All
入选标准
- •Individual should have ITA angle in the range of 18 t0 40, 41 to 55, and greater than 56
- •Individuals free of any dermatological or systemic disorder which would interfere with the results, at the discretion of the investigator.
- •Individuals who have completed a preliminary medical history evaluation.
- •Individuals who have read, understood and signed an informed consent document relating to the specific study to which they are subscribing.
- •Individuals with no known abnormal response to sunlight.
排除标准
- •1.Individuals taking medication which in the opinion of the investigator would mask or interfere with the results.
- •2.Individuals with chronic skin allergies.
- •3.Individuals with suntan or sunburn.
- •4.Individuals with abnormal reaction to the sun.
- •5.Pregnant or lactating females.
- •6.Subjects accustomed to using sun beds.
- •7.Subjects who have participated in an SPF study within the last two months.
结局指标
主要结局
Change in Individual MED (iMED) score
时间窗: Day1, Day2, Day3
次要结局
- Not Applicable(Not Applicable)
研究者
Dr Robin Chugh
CCFT Laboratories
研究点 (1)
Loading locations...
相似试验
尚未招募
Unknown
Efficacy and Safety of Baypure Vitamin C & Ferulic Acid SerumCTRI/2025/10/096426Baypure Lifestyle Pvt Ltd35
尚未招募
1 期
The Safety and Efficacy of Daratumumab in Patients With Refractory Aplastic AnemiaAplastic AnemiaNCT07287228Institute of Hematology & Blood Diseases Hospital, China37
已完成
1 期
Study is designed to assess the safety and tolerability of ceralasertib at increasing doses in combination with other anti-cancer treatment in patients with advanced tumours2023-505006-41-00AstraZeneca AB100
招募中
不适用
A Study to Describe the Effect of Photobiomodulation (Low Level Laser Therapy) in Reducing the Severity and Incidence of Oral Mucositis (Oral Ulceration) in Oral Cancer Patients Undergoing Radiation TreatmentNCT07387978Peter MacCallum Cancer Centre, Australia30
招募中
1 期
A Study of LUCAR-G79D in Subjects With Relapsed/Refractory Systemic Lupus Erythematosus (r/r SLE) and Idiopathic Inflammatory Myopathies (r/r IIM)NCT07331272Nanjing Legend Biotech Co.38